Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2012
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
04/05/2012US20120082715 Stabilized products, processes and devices for preparing the same
04/05/2012US20120082698 Mutants of francisella tularensis and uses thereof
04/05/2012US20120082697 Method for prophylaxis of influenza using vaccine for intranasal administration
04/05/2012US20120082696 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/05/2012US20120082694 Recombinant Viral-Based Malaria Vaccines
04/05/2012US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
04/05/2012US20120082692 Identification, Optimization and Use of Cryptic HLA-A24 Epitopes for Immunotherapy
04/05/2012US20120082691 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
04/05/2012US20120082690 Chaperonin 10 immunosuppression
04/05/2012US20120082689 Method of treatment an oncological disease
04/05/2012US20120082687 Use of cell adhesion inhibitor for the mobilization of antigen presenting cells and immune cells in a cell mixture (AIM) from the peripheral blood and methods of use
04/05/2012US20120082686 Neovascular-Targeted Immunoconjugates
04/05/2012US20120082685 Dock-and-Lock (DNL) Constructs for Human Immunodeficiency Virus (HIV) Therapy
04/05/2012US20120082684 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
04/05/2012US20120082683 Superagonistic Anti-CD28 Antibodies
04/05/2012US20120082682 Il-13 binding protein
04/05/2012US20120082681 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
04/05/2012US20120082680 Antagonists of pcsk9
04/05/2012US20120082679 Antagonists of pcsk9
04/05/2012US20120082678 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
04/05/2012US20120082677 Compositions for the treatment of hcv and hbv
04/05/2012US20120082676 Methods for preventing and treating angioedema
04/05/2012US20120082675 Insulin-like growth factor signaling and integrin
04/05/2012US20120082674 Enterococcus antigens
04/05/2012US20120082673 Human cytokine receptor
04/05/2012US20120082672 Botulinum Neurotoxin B Receptors and Use Thereof
04/05/2012US20120082671 Modulation of activity of neurotrophins
04/05/2012US20120082670 Cd33 binding agents
04/05/2012US20120082669 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
04/05/2012US20120082668 Soluble il-17ra/rc fusion proteins and related methods
04/05/2012US20120082667 Antibodies That Specifically Bind To A Beta Oligomers And Use Thereof
04/05/2012US20120082666 Antibody compositions and methods of use
04/05/2012US20120082665 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
04/05/2012US20120082664 Optimized antibodies that target cd19
04/05/2012US20120082663 Anti-cmet antagonists
04/05/2012US20120082662 Anti-cmet antagonists
04/05/2012US20120082661 Anti-bcma antibodies
04/05/2012US20120082660 Anti-tnf induced apoptosis (atia) diagnostic markers and therapies
04/05/2012US20120082659 Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
04/05/2012US20120082658 Methods for the Treatment of Allergic Diseases
04/05/2012US20120082644 Cytokines and neuroantigens for treatment of immune disorders
04/05/2012US20120082643 Compositions and Methods for Modulating a Cytotoxic T Lymphocyte Immune Response
04/05/2012US20120082618 Prostate cancer diagnosis and treatment
04/05/2012US20120082617 Immunoconjugates with an Intracellularly-Cleavable Linkage
04/05/2012CA2821992A1 Engineered nucleic acids and methods of use thereof
04/05/2012CA2818027A1 Vaccine composition for controlling ectoparasite infestations
04/05/2012CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
04/05/2012CA2813133A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012CA2813064A1 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/05/2012CA2812957A1 Polypeptides that bind to human complement component c5
04/05/2012CA2812893A1 Vaccine
04/05/2012CA2812756A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012CA2812631A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl
04/05/2012CA2812430A1 Humanized anti-tnf-.alpha. antibody and antigen-binding fragment (fab) thereof and use of the same
04/05/2012CA2812306A1 Flavivirus domain iii vaccine
04/05/2012CA2811747A1 Generation, characterization and uses thereof of anti-her3 antibodies
04/05/2012CA2811699A1 Fusion protein for secretory protein expression
04/05/2012CA2810597A1 Improved vaccine compositions
04/05/2012CA2809463A1 Heterologous prime boost vaccination regimen against malaria
04/05/2012CA2809360A1 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
04/05/2012CA2805361A1 Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
04/04/2012EP2436774A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
04/04/2012EP2436696A1 Method of providing disease-specific binding molecules and targets
04/04/2012EP2436695A1 Methods for treating and preventing fibrosis by IL-21 / IL-21R antagonists
04/04/2012EP2436692A2 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies
04/04/2012EP2436691A2 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies
04/04/2012EP2436397A1 Pharmaceutical composition containing antagonist of egf family ligand as component
04/04/2012EP2436395A2 An allergen dosage form
04/04/2012EP2436394A1 Peptide therapy
04/04/2012EP2436393A1 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
04/04/2012EP2435573A2 Expression of recombinant proteins
04/04/2012EP2435572A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
04/04/2012EP2435567A1 Cdc45l peptides and vaccines including the same
04/04/2012EP2435559A1 Simian adenovirus 41 and uses thereof
04/04/2012EP2435479A1 Antigen-binding proteins
04/04/2012EP2435478A1 Antigen-binding proteins
04/04/2012EP2435476A2 Avian derived antibodies
04/04/2012EP2435473A1 Tri- or tetraspecific antibodies
04/04/2012EP2435469A1 Casb7439 constructs
04/04/2012EP2435095A2 Immunomodulatory agent-polymeric compounds
04/04/2012EP2435094A2 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
04/04/2012EP2435093A1 Albumin-amyloid peptide conjugates and uses thereof
04/04/2012EP2435092A2 Nanocarriers possessing components with different rates of release
04/04/2012EP2435079A2 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
04/04/2012EP2435078A1 Methods of treating inflammation
04/04/2012EP2435077A1 Stim2-mediated capacitive calcium entry
04/04/2012EP2435076A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
04/04/2012EP2435075A2 Antigen-binding proteins
04/04/2012EP2435074A1 Extraneous agents testing
04/04/2012EP2435073A1 CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF
04/04/2012EP2435072A2 Proteasome inhibitors and uses thereof
04/04/2012EP2435071A1 Modulators for her2 signaling in her2 expressing patients with gastric cancer
04/04/2012EP2435068A2 Use of 2 anti-sparc antibodies to predict response to chemotherapy
04/04/2012EP2435067A2 Stem cell targeting
04/04/2012EP2435066A1 Assays for influenza virus hemagglutinins
04/04/2012EP2288619B1 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
04/04/2012EP1994145B1 Production of biologically active proteins
04/04/2012EP1791556B1 Modified hiv-1 envelope proteins
04/04/2012EP1694706B1 Modified anti-cd52 antibody
1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 1823